Focal Segmental Glomerulosclerosis Drugs Market Size, Share, Report 2024-2031
Market Overview: The global focal segmental glomerulosclerosis drugs market reached US$ 0.7 billion in 2023 and is expected to reach US$ 1.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disorder characterized by the scarring of kidney tissue, leading to kidney dysfunction. The FSGS drugs market...
0 Commentaires 0 Parts 267 Vue 0 Aperçu